» Articles » PMID: 15708883

Evaluation of the Effect of Nifedipine Upon Myocardial Perfusion and Contractility Using Cardiac Magnetic Resonance Imaging and Tissue Doppler Echocardiography in Systemic Sclerosis

Overview
Journal Ann Rheum Dis
Specialty Rheumatology
Date 2005 Feb 15
PMID 15708883
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Primary myocardial involvement due to microcirculation impairment is common in systemic sclerosis (SSc). Cardiovascular magnetic resonance imaging (MRI) and tissue Doppler echocardiography (TDE) were recently shown to be more sensitive than conventional methods for the respective assessment of myocardial perfusion and contractility. Previous studies have suggested that dihydropyridine-type calcium channel blockers mitigate both myocardial perfusion and function abnormalities.

Objective: To investigate the effects of nifedipine on myocardial perfusion by MRI and on contractility by TDE, in patients with SSc.

Patients And Methods: 18 patients with SSc without clinical heart failure and with normal pulmonary arterial pressure (14 women, 4 men; mean (SD) age 59 (9) years; mean (SD) disease duration 7 (4) years, 10 with diffuse and 8 with limited cutaneous forms) were prospectively evaluated. The MRI perfusion index, determined from time-intensity curves, and systolic and diastolic strain rate determined by TDE were assessed at baseline, after a 72 hour vasodilator washout period, and after 14 days of oral treatment with nifedipine 60 mg/day.

Results: Nifedipine treatment led to a significant increase in the MRI perfusion index (mean (SD) 0.26 (0.07) v 0.19 (0.05) at baseline, p = 0.0003) and in systolic and diastolic strain rate (2.3 (0.6) v 1.5 (0.4) s(-1) at baseline, p = 0.0002, and 4.2 (1.6) v 3.0 (1.2) at baseline, p = 0.0003, respectively).

Conclusion: Fourteen days of treatment with nifedipine simultaneously improves myocardial perfusion and function, as evaluated by highly sensitive and quantitative methods.

Citing Articles

Non-Invasive Cardiac and Vascular Monitoring in Systemic Sclerosis: Impact of Therapy on Subclinical Dysfunction.

Magda S, Gheorghiu A, Mincu R, Ciobanu A, Constantinescu T, Popa E Medicina (Kaunas). 2025; 60(12.

PMID: 39768959 PMC: 11678526. DOI: 10.3390/medicina60122080.


Vasodilator drugs and heart-related outcomes in systemic sclerosis: an exploratory analysis.

Guedon A, Carrat F, Mouthon L, Launay D, Chaigne B, Pugnet G RMD Open. 2024; 10(4.

PMID: 39658051 PMC: 11629012. DOI: 10.1136/rmdopen-2024-004918.


Coronary microvascular dysfunction in autoimmune rheumatic diseases: beyond coronary flow velocity reserve.

Cecere A, Perazzolo Marra M, Zanatta E, Civieri G, Iliceto S, Tona F Front Cardiovasc Med. 2024; 11:1372703.

PMID: 39234606 PMC: 11371758. DOI: 10.3389/fcvm.2024.1372703.


Therapeutic strategies for primary heart involvement in systemic sclerosis.

Batani V, Dagna L, Luca G Rheumatol Immunol Res. 2024; 5(2):72-82.

PMID: 39015843 PMC: 11248560. DOI: 10.1515/rir-2024-0010.


Cardiac magnetic resonance assessment of cardiac involvement in autoimmune diseases.

Gulhane A, Ordovas K Front Cardiovasc Med. 2023; 10:1215907.

PMID: 37808881 PMC: 10556673. DOI: 10.3389/fcvm.2023.1215907.


References
1.
Schwitter J, Nanz D, Kneifel S, Bertschinger K, Buchi M, Knusel P . Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation. 2001; 103(18):2230-5. DOI: 10.1161/01.cir.103.18.2230. View

2.
Shimizu Y, Uematsu M, Shimizu H, Nakamura K, Yamagishi M, Miyatake K . Peak negative myocardial velocity gradient in early diastole as a noninvasive indicator of left ventricular diastolic function: comparison with transmitral flow velocity indices. J Am Coll Cardiol. 1998; 32(5):1418-25. DOI: 10.1016/s0735-1097(98)00394-5. View

3.
Derumeaux G, Mulder P, Richard V, Chagraoui A, Nafeh C, Bauer F . Tissue Doppler imaging differentiates physiological from pathological pressure-overload left ventricular hypertrophy in rats. Circulation. 2002; 105(13):1602-8. DOI: 10.1161/01.cir.0000012943.91101.d7. View

4.
Weidemann F, Jamal F, Kowalski M, Kukulski T, Dhooge J, Bijnens B . Can strain rate and strain quantify changes in regional systolic function during dobutamine infusion, B-blockade, and atrial pacing--implications for quantitative stress echocardiography. J Am Soc Echocardiogr. 2002; 15(5):416-24. DOI: 10.1067/mje.2002.116535. View

5.
Panting J, Gatehouse P, Yang G, Grothues F, Firmin D, Collins P . Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med. 2002; 346(25):1948-53. DOI: 10.1056/NEJMoa012369. View